Evidence map›Paper›PMID 37934667›Full record

ArticleCell reports2023

Cytotoxic CD4 development requires CD4 effectors to concurrently recognize local antigen and encounter type I IFN-induced IL-15.

Priyadharshini Devarajan, Allen M Vong, Catherine H Castonguay, Noah J Silverstein, Olivia Kugler-Umana, Bianca L Bautista, Karen A Kelly, Jeremy Luban, Susan L Swain

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Cell reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. CD4Trends in cancer · 2024
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Priyadharshini Devarajan
Allen M Vong
Catherine H Castonguay
Noah J Silverstein
Olivia Kugler-Umana
Bianca L Bautista
Karen A Kelly
Jeremy Luban
Susan L Swain

Funding

Defining a memory checkpoint for CD4 T cellsR01AI118820 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 2015 to 2019
$2.1M
VACCINE STRATEGIES TO CIRCUMVENT AGE-ASSOCIATED IMMUNE DEFECTSR21AG058758 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 2018 to 2019
$461k
Age-Associated B Cells Specialized for Immunity to Pathogens?R21AG068313 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 2021 to 2022
$461k
Maintaining Robust T Cell Immunity For Broad Protection Against InfluenzaR21AI146532 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 2019 to 2020
$461k
Impact of TcR Signal Strength at the Effector Checkpoint on Protective CD4 T Cell Immunity to Influenza VirusR21AI153120 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 2020 to 2021
$461k
Harnessing Age-Associated B cells for a Universal Influenza Vaccine for the AgedR21AI173593 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 2023 to 2024
$461k
NIAID NIH HHS R01 AI118820NIAID NIH HHS R21 AI146532NIAID NIH HHS R21 AI153120NIAID NIH HHS R21 AI173593NIA NIH HHS R21 AG058758NIA NIH HHS R21 AG068313
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37934667
PMCPMC11649186
OpenAlexW4388398204

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.